GNH USA

Europe — EMA

Ondansetron Noridem

Ondondansetron, the active ingredient in Ondansetron Noridem, is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiation…

Request sourcing

1
Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Noridem, is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult patients. GNH USA supplies Ondansetron Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ondansetron Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron Noridem is a selective 5‑HT3 receptor antagonist that helps ... - Chemotherapy‑induced nausea and vomiting: Prevents the onset of CINV and reduces its severity for patients under treatment with high‑dose cis‑cancer c ​  ​  …  ... ... ... .... .... ... .... ... ...

What are the side effects of Ondansetron?

Common  ....  .... … ...

What precautions apply to Ondansetron?

...

What does Ondansetron interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ondansetron
Route
Intramuscular Use , Intravenous Use
Manufacturer
Noridem Enterprises Ltd
Origin
EU

Related products